How to manage GLP-1s in the hospital
Today's Hospitalist
JUNE 7, 2025
Moreover, because obesity is a chronic disease, “anti-obesity medications should be continued long term, and we can’t stop these medications, just like we wouldn’t stop those for diabetes or hypertension.” The SELECT trial , which was published in the NEJM in November 2023, tested semaglutide vs. placebo.
Let's personalize your content